BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 27, 2010
View Archived Issues
Briakinumab is superior to methotrexate and etanercept in treating psoriasis
Read More
Long-term data disclosed on alemtuzumab for treatment of relapsing-remitting MS
Read More
GM-CSF adjuvant enhances efficacy of AIDS vaccine in rhesus macaques
Read More
BMS-690514 shows potential to treat non-small cell lung cancer
Read More
Combination of BG-12 with IFN-beta 1a or glatiramer acetate is safe in healthy subjects
Read More
Pfizer gains exclusive global rights to commercialize several of Biocon's insulin products
Read More
Vertex Pharma begins phase IIIb telaprevir trial in hepatitis C
Read More
Phase II Androxal trial begins in men with type 2 diabetes and low testosterone
Read More
AstraZeneca presents novel glucocorticoid receptor ligands
Read More
New inhibitors of dual specificity protein kinase TTK presented
Read More
Continuation recommended of phase III LibiGel safety trial
Read More
Boehringer Ingelheim and MacroGenics to codevelop antibody-based therapeutics
Read More
Celtic Therapeutics and Resolvyx Pharma form ophthalmology alliance
Read More
Preliminary data reported from phase II orBec trial in prevention of GVHD
Read More
Essentialis and FDA reach agreement on SPA for diazoxide choline trial
Read More
New inhibitors of HCV NS5A presented
Read More
Roche patents new glucocorticoid receptor antagonists
Read More
ViaDerm delivery system meets endpoints in phase I osteoporosis trial
Read More
Verona Pharma treats first patient in trial of VRP-700 in chronic cough
Read More
MDS to change company name to Nordion
Read More
Inviragen begins phase I trial for DENVax dengue virus vaccine
Read More
MolMed begins enrollment in phase II trial of NGR-hTNF in soft tissue sarcomas
Read More
Daiichi Sankyo receives Japanese approval for new formulations of Cravit
Read More
Interim safety results reported from toxicology study of CEQ-508
Read More